ERIKA CROSETTI

Dr. ERIKA CROSETTI


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2019 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
GSGiovanni SUCCO
Giovanni SUCCO
ECERIKA CROSETTI
ERIKA CROSETTI
The current trend for treatment of intermediate-early advanced laryngeal cancer is essentially oriented toward preservation of organ and laryngeal function, and with a good potential for treating the disease. This goal can be achieved by adopting open laryngeal organ preservation surgery (OLOPS), at present mainly represented by open partial horizontal laryngectomies (OPHLs). An approach using rigorous selection criteria based on both the general condition of the patient and the local and regional extent of the disease gives excellent oncological and functional results in untreated patients. Similar outcomes, albeit slightly worse, are also obtainable in radio-recurrent and laser-recurrent patients. Troublesome postoperative management and the inconsistency of functional recovery are the main limitations for extensive application of this therapeutic strategy. The future direction is represented by simplification of the indications identifying iso-prognostic sub-categories within the T-stage, wider consensus on rehabilitation protocols, hybrid approaches to the larynx, and open minimally invasive access.

31 January 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
ECERIKA CROSETTI
ERIKA CROSETTI
GAGiulia Arrigoni
Giulia Arrigoni
AMAndrea Manca
Andrea Manca
ACAlessandra Caracciolo
Alessandra Caracciolo
IBIlaria Bertotto
Ilaria Bertotto
GSGiovanni Succo
Giovanni Succo
Over the past three decades, the incidence of oropharyngeal squamous cell carcinoma has increased, primarily related to the spread of human papillomavirus. Treatment has always been preferentially unimodal (surgery or radiotherapy) for early stage disease and multimodal (surgery with adjuvant therapy or concomitant chemoradiotherapy) for advanced stages. Recently, the surgical approach has gained renewed interest due to the morbidity of non-surgical treatments and also to technical innovations. We have coined the term 3Des (3D exoscope surgery) to describe the use of the 3D Vitom Exoscope System for transoral surgery of oropharyngeal cancers. During the period from June 2017 to May 2018, 10 patients with oropharyngeal cancer were treated by oropharyngeal surgery with the 3Des approach at FPO IRCCS Institute of Candiolo. The aim of the present prospective study was to evaluate the utility of 3Des for the treatment of early-stage oropharyngeal cancer. 3Des could represent a viable alternative to the operating microscope and robotic surgery thanks to its excellent ability to provide 3D visual information, depth of field, magnification, image contrast, color imaging, and low running costs. It promises great utility in the learning process, with the possibility of recording in high definition.

13 March 2019 in Cancers
Verified
Journal Article
Open access
PDF file
GSGiovanni SUCCO
Giovanni SUCCO
SCStefano Cirillo
Stefano Cirillo
IBIlaria Bertotto
Ilaria Bertotto
EMElena Maldi
Elena Maldi
DBDavide Balmativola
Davide Balmativola
ECERIKA CROSETTI
ERIKA CROSETTI
Background: The aim of this retrospective study was to identify different radiological features in intermediate–advanced laryngeal cancer (LC) associated with arytenoid fixation, in order to differentiate cases still safely amenable to conservative treatment by partial laryngectomy or chemoradiotherapy. Methods: 29 consecutive patients who underwent open partial horizontal laryngectomies (OPHLs), induction chemotherapy followed by radiotherapy in the case of >50% response (IC + RT) or total laryngectomy were classified as: pattern I (supraglottic LC fixing the arytenoid due to weight effect), pattern II (glottic LC involving the posterior paraglottic space and spreading toward the crico-arytenoid joint and infraglottic extension 10 mm) and pattern IV (transglottic and infraglottic LC with massive crico-arytenoid unit involvement, reaching the hypopharyngeal submucosa). All glottic cancers treated with surgery were studied by a cross sectional approach. Results: A substantial agreement between the work-up and the pathology results has been obtained in each of the subcategories. Three-year disease-free survivals, local control and freedom from laryngectomy were significantly better in pattern II compared to pattern III–IV. Conclusions: LC showing fixed arytenoid due to weight effect or posterior paraglottic space involvement with infraglottic extension <10 mm assessed at the true vocal cord midline are still safely manageable by OPHL or IC + RT.

1 August 2019 in Acta Otorhinolaryngologica Italica
Verified
Journal Article
Open access
PDF file
ECERIKA CROSETTI
ERIKA CROSETTI
ABA. Bertolin
A. Bertolin
GMGabriele Molteni
Gabriele Molteni
IBIlaria Bertotto
Ilaria Bertotto
DBD. Balmativola
D. Balmativola
GSGiovanni SUCCO
Giovanni SUCCO
In choosing the best surgical treatment (total or partial laryngectomy) for patients affected by laryngeal squamous cell carcinoma (SCC), itis still necessary to identify a link between prognostic factors and oncological outcomes. A retrospective analysis of clinical outcomes of819 patients affected by laryngeal cancer who underwent OPHL type II and III between 1995 to 2014 was carried out. Focusing on recurrenceand its site (local, regional or distant), our cohort has been divided in two groups: patients showing recurrence (n = 108) vs thosewithout recurrence (n = 711). Thirteen clinical-pathological parameters have been studied by univariate and multivariate analysis to identifypossible correlations between recurrence and oncological outcomes (overall survival (OS), disease free survival (DFS), disease specific survival(DSS), laryngectomy free survival (LSF), laryngectomy free freedom (FFL). In multivariate analysis, we found 4 negative prognosticfactors for recurrence: site of tumour (> supraglottic), cartilage invasion (> if present), perineural invasion (> if present) and type of OPHL(> in OPHL type III). The knowledge and detection of negative prognostic factors for the risk of recurrence (pN classification, cartilageinvolvement, perineural invasion, and thus the type of surgical treatment adopted) could increase the already well-established potentialityof OPHLs in treating cases with a safe indication after careful discussion in the tumour board.

22 June 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
ECERIKA CROSETTI
ERIKA CROSETTI
GAGiulia Arrigoni
Giulia Arrigoni
ASAndrea Elio Sprio
Andrea Elio Sprio
GSGiovanni Succo
Giovanni Succo
Objectives: Pharyngocutaneous fistula (PCF) is a troublesome complication after total laryngectomy. The “Fistula zero” project aims to reduce the number of PCF by following a detailed protocol based on three fundamental key points. Materials and Methods: The Fistula zero project included 77 patients who underwent total laryngectomy in the period from January 2019 to December 2020. The protocol consisted of three main aspects: the systematic placement of a Har-El salivary bypass tube, the continuous horizontal watertight pharyngeal suture using a barbed suture, onlay insetting of a pedicled flap in pre-treated patients. Results: One case of PCF (1.3%) and three small blind fistulas (3.9%) were observed in this series. The mean length of hospitalization was 18 days. Conclusion: Pharyngocutaneous fistula (PCF) prolongs hospitalization and delays adjuvant treatments. Thanks to a strict adherence to the protocol, it was possible to reduce PCF rates, avoiding lengthy hospitalization and additional surgical procedures.

1 October 2021 in Acta Otorhinolaryngologica Italica
Verified
Journal Article
Open access
PDF file
ECERIKA CROSETTI
ERIKA CROSETTI
GAGiulia Arrigoni
Giulia Arrigoni
ACAlessandra Caracciolo
Alessandra Caracciolo
MTMartina Tascone
Martina Tascone
AMAndrea Manca
Andrea Manca
GSGiovanni Succo
Giovanni Succo
Objective. The recent introduction of 3D exoscopic surgery has engendered interesting technical improvements in head and neck surgery. The main goal of this study was to describe the application of 3D exoscopic technology on a wide range of pathologies of the neck, benign and malignant, through a minimally invasive retroauricular approach.Methods. In the period January-December, 2019, 40 consecutive patients underwent neck surgery with a retroauricular approach, enhanced by using a 3D exoscope at the Head and Neck Oncological Unit of Candiolo Cancer Institute.Results. Data regarding time to drain removal, length of hospitalisation, degree of pain experienced, need for opioid drugs during hospitalisation and after discharge, and intraoperative and post-operative complications were collected. All patients were followed for a minimum of 90 days with possible complications evaluated at each post-operative visit. Post-operative outcomes were evaluated at 3 months after surgery.Conclusions. The current study indicates that VITOM-3D-assisted retroauricular neck surgery (RANS-3D) may be an interesting approach for neck surgery. The hybrid execution of neck dissection under direct and exoscopic vision represents a valid alternative to videoassisted endoscopic- and robot-assisted techniques.